HIS
REGN icon

Harvest Investment Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Harvest Investment Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,759
Closed -$3.22M – 316
2021
Q2 		$3.22M Sell
5,759
-374
-6% -$189K 1.35% 10
2021
Q1 		$2.9M Buy
6,133
+39
+0.6% +$19K 1.31% 10
2020
Q4 		$2.94M Buy
6,094
+2,607
+75% +$1.41M 1.52% 10
2020
Q3 		$1.95M Buy
3,487
+2,253
+183% +$1.37M 1.12% 19
2020
Q2 		$769K Sell
1,234
-455
-27% -$258K 0.46% 54
2020
Q1 		$824K Buy
+1,689
New +$697K 1.1% 27

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Harvest Investment Services's REGN Position: Q3 2021 in Review

Harvest Investment Services sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 5,759 shares — an estimated $3.22M sold.

Harvest Investment Services first reported a position in REGN in Q1 2020 and held it in 6 quarters. The position peaked at $3.22M in Q2 2021. 1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Harvest Investment Services reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Harvest Investment Services sold 5,759 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $3.22M.
  • Harvest Investment Services first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Harvest Investment Services's Regeneron Pharmaceuticals position peaked at $3.22M in Q2 2021.
  • 1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Harvest Investment Services's 13F filing for Q3 2021, filed 29 Oct 2021.